Kerri Aronson, M.D.
Kerri Aronson, M.D.
Locations and Appointments
Please contact the doctor's office to verify that your insurance is accepted.
*Indicates this doctor is no longer accepting new patients with this insurance plan.
- HMO
- Medicare
- PPO
- EPO/POS
- CHP
- Blue Access
- Blue Connection
- EPO
- HMO
- Mediblue (Senior)
- PPO
- CBP
- Medicaid
- Medicare
- Freedom
- Liberty
- Medicare Advantage
- Community Plan
- Medicare
- HMO
- Medicare
About Kerri Aronson, M.D.
Dr. Aronson's career is dedicated to the care of patients with interstitial lung disease (ILD) and pulmonary fibrosis. She is an expert in patient-centered outcomes in ILD, focusing on defining and elevating outcome measures for clinical practice and clinical trials that are most meaningful to patients. Dr. Aronson is developing a patient-reported outcome that measures quality of life in patients with Chronic Hypersensitivity Pneumonitis (CHP), to better define, understand, and address the challenges associated with antigen identification and avoidance in patients with CHP.
Dr. Aronson has received the Weill Cornell Medicine Fund for the Future and Pulmonary Fibrosis Foundation Awards. She is a co-investigator on a national ILD registry and clinical trials.
-
M.S.Weill Graduate School of Medical Sciences of Cornell University2020
-
M.D.State University of New York Upstate Medical University2012
-
B.S.Syracuse University2008
-
Assistant Attending PhysicianNewYork-Presbyterian Hospital
-
Assistant Professor of MedicineWeill Cornell Medical College, Cornell University
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
No External Relationships Reported